Skip to main content
Qualigen Therapeutics, Inc. logo

Qualigen Therapeutics, Inc. — Investor Relations & Filings

Ticker · QLGN ISIN · US74754R1032 US Professional, scientific and technical activities
Open in API
Filings indexed 618 across all filing types
Latest filing 2017-08-25 Proxy Solicitation & In…
Country US United States of America
Listing US QLGN

About Qualigen Therapeutics, Inc.

https://qlgntx.com/

Qualigen Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel treatments for cancer. The company's efforts are directed toward creating therapeutics for both adult and pediatric patients, with a particular emphasis on rare cancers and areas of high unmet medical need. Its development approach combines internal capabilities with collaborations from major cancer research institutions. The company's investigational oncology pipeline includes programs such as QN-302, a Pan-RAS inhibitor platform, and QN-247.

Recent filings

Filing Released Lang Actions
Proxy Solicitation & Information Statement 2017
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A filing, which is a proxy statement or related materials filed with the SEC. It is titled 'Definitive Additional Materials' and contains a letter urging stockholders to vote on proposals related to increasing authorized shares and amending the equity incentive plan. The content is focused on soliciting votes for a shareholder meeting and providing information about the proposals. This matches the description of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document is not a full annual report, earnings release, or other financial report, but rather proxy solicitation materials. Therefore, the correct classification is PSI with high confidence.
2017-08-25 English
DEF 14A Filing
Proxy Solicitation & Information Statement
2017-08-09 English
Regulatory Filings 2017
Regulatory Filings
2017-08-08 English
Interim / Quarterly Report 2017
Interim / Quarterly Report Q2 2017
2017-08-07 English
Proxy Solicitation & Information Statement 2017
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a letter from legal counsel to the SEC responding to comments on a Preliminary Proxy Statement on Schedule 14A. It discusses amendments to the proxy statement and addresses SEC staff comments regarding disclosure about share issuance plans and dilution effects. The document references a Preliminary Proxy Statement and an Amendment to it, which are materials related to proxy solicitation. The content is not the proxy statement itself but a correspondence about it. Given the focus on proxy materials and the nature of the document as a response to SEC comments on a Schedule 14A filing, the appropriate classification is Proxy Solicitation & Information Statement (PSI). The document length is short (3070 characters), and it is not a full report but a comment response letter, reinforcing that it is not an Annual Report or similar. Therefore, the best fit is PSI.
2017-08-04 English
Proxy Solicitation & Information Statement 2017
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A proxy statement filed with the SEC, as indicated by the header and references to Rule 14a-101 and the Securities Exchange Act of 1934. It is a proxy statement for a special meeting of stockholders of Ritter Pharmaceuticals, Inc., detailing proposals for shareholder voting, including amendments to the certificate of incorporation and equity incentive plans. The document includes voting instructions, meeting details, and board recommendations. It is not an announcement of voting results, nor a report of financial results or management discussion. It is a solicitation document sent to shareholders to provide information and request votes for the meeting. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI). The document length (15,000 characters) and content confirm it is the full proxy statement, not just a brief announcement or notice.
2017-08-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.